Clinical Trial Update: Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lamivudine in combination with adefovir for chronic hepatitis B in people with and without HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Adefovir (adefovir)
• Lamivudine (lamivudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Chronic Hepatitis B | Phase 3 | Status: COMPLETED